Back

The association of extracellular vesicle (EV)-cargo miR-330-3p with postoperative delirium and a potential mechanism of tau phosphorylation and neuron toxicity

Fujimori, T.; Chakraborty, S.; Miyagawa, A.; Tak, H.; Yamaguchi, A.; Hogue, C. W.; Brown, C. H.; Das, S.

2026-04-01 molecular biology
10.64898/2026.03.30.715460 bioRxiv
Show abstract

BackgroundPostoperative delirium (POD) is a frequent and severe neurocognitive complication following cardiac surgery, associated with poor long-term outcomes. The underlying mechanisms are unclear, and objective biomarkers are urgently needed. MethodsWe used pre- and post-operative plasma samples from 59 patients undergoing cardiac surgery in three separate studies with rigorous delirium assessment using the Confusion Assessment Method in a case-control design. Small extracellular vesicles (sEVs) were isolated from plasma, and their miRNA cargo was profiled using RNA sequencing. Target miRNAs were validated by qRT-PCR, and digital PCR (dPCR). The functional impact of the lead candidate miRNA was investigated in vitro by assessing tau phosphorylation and cell viability in HT22 neuronal cell line. ResultsThere were no differences in sEV morphology or numbers between patients with and without POD. While three candidate miRNAs were initially validated by qRT-PCR, subsequent dPCR analysis confirmed that only the perioperative change in plasma sEV-cargo miR-330-3p expression was significantly greater in patients who developed POD (n = 20) compared with those who did not (n = 20) (5.22 copies/L plasma; 95% Confidence Interval (CI), 1.187 to 9.256; p = 0.0139). Receiver operating characteristic curve analysis for this change yielded an area under the curve of 0.745 (95% CI, 0.589 to 0.901). In vitro overexpression of miR-330-3p in a neuronal cell line significantly increased the phosphorylation of tau at Ser199 (p < 0.0001) and Ser396 (p < 0.001) and reduced cell viability (p < 0.001). ConclusionsOur findings suggest that sEV-bound miR-330-3p increases in patients with POD after cardiac surgery. In vitro results suggest a potential pathogenic role for miR-330-3p, linking a systemic signal to tau-related neuronal injury. Clinical PerspectiveO_ST_ABSWhat Is New?C_ST_ABSO_LIThis study identifies a specific perioperative increase in small extracellular vesicle (sEV)-cargo miR-330-3p in patients with postoperative delirium (POD) following cardiac surgery. C_LIO_LIWe provide the first evidence that miR-330-3p directly induces tau hyperphosphorylation and reduces neuronal viability in vitro, establishing a potential mechanistic link between systemic sEV signaling and neurodegeneration. C_LI What Are the Clinical Implications?O_LIThe measurement of perioperative change in miR-330-3p could serve as an objective biological marker to assist in the early identification and risk stratification of patients at high risk for POD. C_LIO_LIThe identified miR-330-3p/tau pathway represents a potential new therapeutic target; future interventions aimed at inhibiting this specific miRNA might help prevent or mitigate POD-related neuronal injury. C_LIO_LIThese findings emphasize the importance of monitoring dynamic sEV-cargo changes to better understand and manage perioperative neurocognitive disorders. C_LI

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Annals of Neurology
57 papers in training set
Top 0.1%
29.5%
2
PLOS ONE
4510 papers in training set
Top 21%
9.0%
3
British Journal of Anaesthesia
14 papers in training set
Top 0.1%
6.7%
4
Neurobiology of Disease
134 papers in training set
Top 1%
4.6%
5
Circulation
66 papers in training set
Top 0.9%
3.9%
50% of probability mass above
6
Journal of the American Heart Association
119 papers in training set
Top 2%
3.8%
7
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.1%
1.9%
8
Scientific Reports
3102 papers in training set
Top 53%
1.9%
9
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.6%
10
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.4%
1.4%
11
PLOS Biology
408 papers in training set
Top 12%
1.4%
12
ACS Omega
90 papers in training set
Top 3%
1.0%
13
Clinical Epigenetics
53 papers in training set
Top 0.8%
1.0%
14
BMC Cardiovascular Disorders
14 papers in training set
Top 1%
0.8%
15
Biomedicines
66 papers in training set
Top 2%
0.8%
16
Nature Communications
4913 papers in training set
Top 60%
0.8%
17
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.8%
18
Journal of Stroke and Cerebrovascular Diseases
12 papers in training set
Top 0.5%
0.8%
19
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.3%
0.8%
20
Journal of the American Geriatrics Society
12 papers in training set
Top 0.2%
0.8%
21
Molecular Neurobiology
50 papers in training set
Top 1%
0.7%
22
BMC Psychiatry
22 papers in training set
Top 0.9%
0.7%
23
Medicine
30 papers in training set
Top 2%
0.7%
24
Age and Ageing
27 papers in training set
Top 0.5%
0.7%
25
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.5%
0.5%
26
International Journal of Molecular Sciences
453 papers in training set
Top 18%
0.5%
27
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.5%
28
FEBS Open Bio
29 papers in training set
Top 0.8%
0.5%
29
Cells
232 papers in training set
Top 8%
0.5%
30
Molecular Psychiatry
242 papers in training set
Top 4%
0.5%